Literature DB >> 20425849

Lung function testing in preschool-aged children with cystic fibrosis in the clinical setting.

Catherine L Gangell1, Graham L Hall, Stephen M Stick, Peter D Sly.   

Abstract

In cystic fibrosis (CF) lung function testing is a means of monitoring progression of lung disease. The preschool years have often been referred to as the "silent years" due to the previous lack suitable measures of lung function testing in this age group. This review outlines the various techniques of lung function testing in preschool children with CF in the clinical setting. This includes measures requiring tidal breathing including the forced oscillation technique, the interrupter technique, plethysmography, and multiple breath washout, as well as spirometry that requires respiratory maneuvers. We describe the feasibility and variability of different lung function methods used in preschoolers and report measurements made during tidal breathing have greater feasibility, although greater variability compared to spirometry. We also report associations with lung function and markers of CF lung disease. In the preschool age group measurements made during tidal breathing may be more appropriate in the clinic setting than those that require a higher degree of cooperation and specific respiratory maneuvers.maneuvers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425849     DOI: 10.1002/ppul.21192

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  6 in total

Review 1.  Pulmonary function testing in young children.

Authors:  Hugo Escobar; Terrence W Carver
Journal:  Curr Allergy Asthma Rep       Date:  2011-12       Impact factor: 4.806

2.  "Reactance inversion" at low frequencies in a child undergoing treatment of a cystic fibrosis exacerbation.

Authors:  Julian Lewis Allen; Clement L Ren; Joseph McDonough; Charles C Clem
Journal:  Pediatr Investig       Date:  2019-12-21

3.  Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop.

Authors:  Jean Bousquet; James E Gern; Fernando D Martinez; Josep M Anto; Christine C Johnson; Patrick G Holt; Robert F Lemanske; Peter N Le Souëf; Robert S Tepper; Erika R M von Mutius; S Hasan Arshad; Leonard B Bacharier; Allan Becker; Kathleen Belanger; Anna Bergström; David I Bernstein; Michael D Cabana; Kecia N Carroll; Mario Castro; Philip J Cooper; Matthew W Gillman; Diane R Gold; John Henderson; Joachim Heinrich; Soo-Jong Hong; Daniel J Jackson; Thomas Keil; Anita L Kozyrskyj; Karin C Lødrup Carlsen; Rachel L Miller; Isabelle Momas; Wayne J Morgan; Patricia Noel; Dennis R Ownby; Mariona Pinart; Patrick H Ryan; Julie M Schwaninger; Malcolm R Sears; Angela Simpson; Henriette A Smit; Debra A Stern; Padmaja Subbarao; Rudolf Valenta; Xiaobin Wang; Scott T Weiss; Robert Wood; Anne L Wright; Rosalind J Wright; Alkis Togias; Peter J Gergen
Journal:  J Allergy Clin Immunol       Date:  2014-03-15       Impact factor: 10.793

4.  Clinical Implications of Oscillatory Lung Function during Methacholine Bronchoprovocation Testing of Preschool Children.

Authors:  Sun Hee Choi; Youn Ho Sheen; Mi Ae Kim; Ji Hyeon Baek; Hey Sung Baek; Seung Jin Lee; Jung Won Yoon; Yeong Ho Rha; Man Yong Han
Journal:  Biomed Res Int       Date:  2017-06-27       Impact factor: 3.411

Review 5.  Toward the Establishment of New Clinical Endpoints for Cystic Fibrosis: The Role of Lung Clearance Index and Cardiopulmonary Exercise Testing.

Authors:  Elpis Hatziagorou; Asterios Kampouras; Vasiliki Avramidou; Ilektra Toulia; Elisavet-Anna Chrysochoou; Maria Galogavrou; Fotios Kirvassilis; John Tsanakas
Journal:  Front Pediatr       Date:  2021-02-25       Impact factor: 3.418

6.  Pulmonary function parameters and use of bronchodilators in patients with cystic fibrosis.

Authors:  Lucia Harumi Muramatu; Roberto Stirbulov; Wilma Carvalho Neves Forte
Journal:  J Bras Pneumol       Date:  2013 Jan-Feb       Impact factor: 2.624

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.